Hana Doleželová
Masaryk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hana Doleželová.
Reports of Practical Oncology & Radiotherapy | 2013
Tomáš Kazda; Petr Pospíšil; Hana Doleželová; Radim Jančálek; Pavel Šlampa
Several studies focusing on brain irradiation are in progress. Reflecting updates of relevant outcomes in palliative treatment of patients suffering from brain metastases, the primary objective of these studies is the evaluation of neurocognitive function and quality of life. Improvements of technology in radiation oncology allows us to spare the hippocampal region while appropriately irradiating other parts of brain tissue. Irradiation of the hippocampus region is likely to lead to manifestations of adverse events with a subsequent impact on patients quality of life, which is in fact an improper approach in palliative medicine. Ongoing studies evaluate results of hippocampus avoiding radiotherapy compared to standard whole brain radiotherapy. Incorporation of neurocognitive function assessment may result in the confirmation of superiority of sparing the region of hippocampus and thus change current style of providing brain irradiation.
PLOS ONE | 2016
Iveta Selingerová; Hana Doleželová; Ivanka Horová; Stanislav Katina; Jiří Zelinka
Purpose We reviewed the survival time for patients with primary brain tumors undergoing treatment with stereotactic radiation methods at the Masaryk Memorial Cancer Institute Brno. We also identified risk factors and characteristics, and described their influence on survival time. Methods In summarizing survival data, there are two functions of principal interest, namely, the survival function and the hazard function. In practice, both of them can depend on some characteristics. We focused on nonparametric methods, propose a method based on kernel smoothing, and compared our estimates with the results of the Cox regression model. The hazard function is conditional to age and gross tumor volume and visualized as a color-coded surface. A multivariate Cox model was also designed. Results There were 88 patients with primary brain cancer, treated with stereotactic radiation. The median survival of our patient cohort was 47.8 months. The estimate of the hazard function has two peaks (about 10 months and about 40 months). The survival time of patients was significantly different for various diagnoses (p≪0.001), KI (p = 0.047) and stereotactic methods (p = 0.033). Patients with a greater GTV had higher risk of death. The suitable threshold for GTV is 20 cm3. Younger patients with a survival time of about 50 months had a higher risk of death. In the multivariate Cox regression model, the selected variables were age, GTV, sex, diagnosis, KI, location, and some of their interactions. Conclusion Kernel methods give us the possibility to evaluate continuous risk variables and based on the results offer risk-prone patients a different treatment, and can be useful for verifying assumptions of the Cox model or for finding thresholds of continuous variables.
Neoplasma | 2008
Hana Doleželová; Pavel Šlampa; Barbora Ondrová; Jana Gombošová; Štěpánka Sovadinová; Tomáš Novotný; Karol Bolčák; Jana Růžičková; Ludmila Hynková; Marie Forbelská
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | 2012
Hana Doleželová; Ludmila Hynková; Petr Pospíšil; Tomáš Kazda; Pavel Šlampa; Irena Čoupková; I. Šiková; Fardus P; Tomáš Svoboda; Jan Garčic; M. Vrzal; Iveta Selingerová; Ivanka Horová
Onkologie | 2008
Ludmila Hynková; Hana Doleželová
Klinická onkologie | 2015
Hana Doleželová; Petra Hübnerova; Štěpánka Sovadinová; Aleš Kudláček; Ludmila Hynková; Pavel Šlampa
Onkologie | 2013
Hana Doleželová; Petr Pospíšil; Pavel Šlampa; Irena Čoupková; Jan Garčic; Pavel Fadrus; Tomáš Svoboda; Iveta Selingerová; Ivanka Horová
Archive | 2013
Hana Doleželová; Pavel Šlampa
Archive | 2012
Ludmila Hynková; Pavel Šlampa; Petr Burkoň; Petr Čoupek; Irena Čoupková; Hana Doleželová; Jana Garčicová; Jana Gombošová; Petra Hübnerova; Tomáš Kazda; Eva Kocmanová; Libor Komínek; Pavel Krupa; Aleš Kudláček; Pavla Navrátilová; Tomáš Novotný; Barbora Ondrová; Petr Pospíšil; Denis Princ; Marek Slávik; Miroslava Sláviková; Silvia Sláviková; Štěpánka Sovadinová; Blažena Syptáková; Pavel Tobiáš; Jana Zitterbartová; Jana Badurová; Jitka Veselá; Radka Bartlová; David Dvořák
Klinická onkologie | 2012
Hana Doleželová; Ludmila Hynková; Petr Pospíšil; Tomáš Kazda; Pavel Šlampa; Irena Čoupková; I. Šiková; Pavel Fadrus; Tomáš Svoboda; Jan Garčic; M. Vrzal; Iveta Selingerová; Ivanka Horová